%0 Journal Article
%T Wernicke's encephalopathy treated with high dose intravenous thiamine: a case report.
%A Alamir M
%A Cantu-Weinstein A
%A Branning R
%A Weleff J
%A Anand A
%J J Addict Dis
%V 0
%N 0
%D 2024 Jul 1
%M 38946394
%F 2.065
%R 10.1080/10550887.2024.2365002
%X Wernicke's encephalopathy (WE) is a dangerous and potentially fatal neurological condition associated with thiamin deficiency. The standard treatment for WE is intravenous (IV) thiamin, but limited research describes optimal dosing. We present a case of a 40-year-old male with severe alcohol use disorder (AUD) and chronic malnourishment who developed WE. Upon administration of 100 mg IV thiamin, symptoms of WE persisted, but when the dose was increased to 500 mg, altered mental status and ophthalmoplegia resolved rapidly. IV thiamin is a reliable and low-risk treatment for WE, even when administered at high doses. High-dose IV thiamin (i.e., >/100 mg) can treat neurological symptoms and cognitive dysfunction in WE and should be considered for first-line treatment. Further study of WE diagnostic and treatment guidelines is warranted to maximize recovery potential.